RxDoctor Payments Data

Scott Rodig, MD

Anatomic Pathology & Clinical Pathology · Boston, MANPI 1154388239

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $9,690 of the $13,736 with a category attached, or 70.6%. E.r. Squibb & Sons, L.L.C. accounts for 81.6% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2019 at $8,989 and has fallen 74.7% since, to $2,273 in 2023. Among anatomic pathology & clinical pathology clinicians in MA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$13,736in general payments, 2019–2025

Across 38 payments — averaging $361.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • E.r. Squibb & Sons, L.L.C.$11K
  • Gilead$2K
  • Bristol Myers Squibb$114
$418,397in research payments, 2019–2025

Across 9 payments — averaging $46,489 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Gilead$345K
  • Merck$73K

What the payments were for

  • Consulting fees$2,25016%
  • Travel & lodging$9,69071%
  • Food & beverage$1,79513%

General payments by program year

19
20
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
E.r. Squibb & Sons, L.L.C.34$11,202
Gilead(2 entities)3$2,420
Bristol Myers Squibb1$114

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$13,736 in reported general payments places this provider in the 90th percentile of 196 anatomic pathology & clinical pathology providers in Massachusetts.

See all anatomic pathology & clinical pathology providers in Massachusetts

Medicare billing

Part B allowed, 2024
$71,806
Medicare patients
641
Services billed
1,856

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other anatomic pathology & clinical pathology in Boston

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →